> top > docs > PMC:7105881 > spans > 53774-57072 > annotations

PMC:7105881 / 53774-57072 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1665 28-36 Species denotes MERS-CoV Tax:1335626
1668 65-73 Species denotes SARS-CoV Tax:694009
1669 132-140 Species denotes MERS-CoV Tax:1335626
1671 355-363 Species denotes MERS-CoV Tax:1335626
1684 835-843 Species denotes MERS-CoV Tax:1335626
1685 1033-1041 Species denotes MERS-CoV Tax:1335626
1686 1176-1180 Species denotes mice Tax:10090
1687 1500-1504 Species denotes mice Tax:10090
1688 1566-1577 Species denotes recombinant Tax:575864
1689 1271-1279 Chemical denotes Freund’s
1690 1281-1289 Chemical denotes aluminum MESH:D000535
1691 1291-1313 Chemical denotes Monophosphoryl lipid A MESH:C048436
1692 1315-1330 Chemical denotes Montanide ISA51 MESH:C477385
1693 1335-1339 Chemical denotes MF59 MESH:C089950
1694 1518-1531 Disease denotes CoV infection MESH:D018352
1695 1695-1708 Disease denotes CoV infection MESH:D018352
1705 2427-2432 Gene denotes IFN-γ Gene:3458
1706 2534-2561 Gene denotes tumor necrosis factor-alpha Gene:7124
1707 2563-2568 Gene denotes TNF-α Gene:7124
1708 2574-2587 Gene denotes interleukin 4 Gene:3565
1709 2589-2593 Gene denotes IL-4 Gene:3565
1710 2036-2040 Species denotes mice Tax:10090
1711 2048-2056 Species denotes MERS-CoV Tax:1335626
1712 2500-2504 Chemical denotes Alum MESH:C041524
1713 2225-2243 Disease denotes MERS-CoV infection MESH:D018352
1718 2749-2757 Species denotes MERS-CoV Tax:1335626
1719 2787-2795 Species denotes MERS-CoV Tax:1335626
1720 2933-2937 Species denotes mice Tax:10090
1721 3256-3274 Disease denotes MERS-CoV infection MESH:D018352

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T309 641-648 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T310 1072-1079 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T311 1133-1141 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T312 1148-1152 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T313 1306-1311 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T314 1366-1373 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T315 1406-1413 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T316 1589-1596 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T317 1734-1738 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T318 1770-1777 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T319 1989-1996 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T320 2198-2206 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T321 2376-2383 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T322 2445-2450 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T323 2476-2483 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T324 2574-2587 Body_part denotes interleukin 4 http://purl.org/sig/ont/fma/fma264831
T325 2574-2585 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T326 2607-2612 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T327 3158-3165 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p63268s31 2171-2197 MPA denotes local mucosal neutralizing

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T268 65-73 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T269 1522-1531 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T270 1699-1708 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T271 2234-2243 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T272 2534-2539 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070
T273 3265-3274 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T642 182-183 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T643 541-542 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T644 717-723 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T645 1031-1032 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T646 1091-1093 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T647 1146-1152 http://purl.obolibrary.org/obo/CL_0000084 denotes T-cell
T648 1312-1313 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T649 1564-1565 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T650 1732-1738 http://purl.obolibrary.org/obo/CL_0000084 denotes T-cell
T651 2046-2047 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T652 2078-2080 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T653 2443-2450 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T654 2534-2561 http://purl.obolibrary.org/obo/PR_000000134 denotes tumor necrosis factor-alpha
T655 2605-2612 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T656 2785-2786 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T657 2810-2812 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T658 2840-2844 http://purl.obolibrary.org/obo/CLO_0001757 denotes at 1
T659 2989-2990 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T660 3007-3009 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T661 3109-3113 http://purl.obolibrary.org/obo/CLO_0001757 denotes at 1

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T21886 211-218 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T99651 248-257 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T29434 281-288 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T79533 402-410 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T96322 641-648 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T57469 910-919 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T32156 1072-1079 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T23740 1198-1206 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T82040 1260-1269 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T77416 1281-1289 Chemical denotes aluminum http://purl.obolibrary.org/obo/CHEBI_28984
T6712 1306-1313 Chemical denotes lipid A http://purl.obolibrary.org/obo/CHEBI_25051|http://purl.obolibrary.org/obo/CHEBI_47040|http://purl.obolibrary.org/obo/CHEBI_58712
T9414 1306-1311 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T76587 1366-1373 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T85274 1406-1413 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T7641 1589-1596 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T73438 1602-1606 Chemical denotes alum http://purl.obolibrary.org/obo/CHEBI_74768
T59817 1615-1624 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T38893 1770-1777 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T4984 1800-1809 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T8227 1989-1996 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T92382 1997-2005 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T19118 2376-2383 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T68288 2476-2483 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T41397 2556-2561 Chemical denotes alpha http://purl.obolibrary.org/obo/CHEBI_30216
T41514 2589-2591 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T26508 3158-3165 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T15 2534-2539 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T108 815-831 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T109 937-953 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T110 1887-1903 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T111 1960-1976 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T112 2132-2157 http://purl.obolibrary.org/obo/GO_0002456 denotes cellular immune responses
T113 2132-2157 http://purl.obolibrary.org/obo/GO_0002449 denotes cellular immune responses
T114 2132-2157 http://purl.obolibrary.org/obo/GO_0002443 denotes cellular immune responses
T115 2540-2548 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T116 2540-2548 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T117 2540-2548 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T118 2540-2548 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T119 2876-2901 http://purl.obolibrary.org/obo/GO_0002456 denotes cellular immune responses
T120 2876-2901 http://purl.obolibrary.org/obo/GO_0002449 denotes cellular immune responses
T121 2876-2901 http://purl.obolibrary.org/obo/GO_0002443 denotes cellular immune responses

2_test

Id Subject Object Predicate Lexical cue
32265848-25445336-36511228 757-761 25445336 denotes 2015
32265848-25405618-36511229 985-989 25405618 denotes 2014
32265848-25640653-36511230 1005-1009 25640653 denotes 2016
32265848-25640653-36511231 1547-1551 25640653 denotes 2016
32265848-25405618-36511232 1823-1827 25405618 denotes 2014
32265848-25405618-36511234 2645-2649 25405618 denotes 2014
32265848-25874632-36511235 3044-3048 25874632 denotes 2015

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T291 0-53 Sentence denotes Potential Factors Affecting MERS-CoV Subunit Vaccines
T292 54-334 Sentence denotes Similar to SARS-CoV subunit vaccines, the immunogenicity and/or protection of MERS-CoV subunit vaccines may also be affected by a number of factors, such as antigen sequences, fragment lengths, adjuvants, vaccination pathways, antigen doses, immunization doses and intervals used.
T293 335-763 Sentence denotes As described above, MERS-CoV subunit vaccines containing different antigens or fragment lengths, particularly those based on the RBD, have apparently variable immunogenicity and/or protective efficacy, and a critical neutralizing domain that contains an RBD fragment corresponding to residues 377–588 of S protein elicits the highest neutralizing antibodies among several fragments tested (Ma et al., 2014b; Zhang et al., 2015).
T294 764-1011 Sentence denotes Adjuvants play an essential role in enhancing host immune responses to MERS-CoV subunit vaccines, including those based on the RBD, and different adjuvants can promote host immune responses to variant levels (Lan et al., 2014; Zhang et al., 2016).
T295 1012-1235 Sentence denotes For example, while a MERS-CoV RBD subunit vaccine (S377-588 protein fused with Fc) alone induced detectable neutralizing antibody and T-cell responses in immunized mice, inclusion of an adjuvant enhanced its immunogenicity.
T296 1236-1553 Sentence denotes Particularly, among the adjuvants (Freund’s, aluminum, Monophosphoryl lipid A, Montanide ISA51 and MF59) conjugated with this RBD protein, MF59 could best potentiate the protein to induce the highest-titer anti-S antibodies and neutralizing antibodies, protecting mice against MERS-CoV infection (Zhang et al., 2016).
T297 1554-1829 Sentence denotes Moreover, a recombinant RBD (rRBD) protein plus alum and CpG adjuvants elicited the highest neutralizing antibodies against pseudotyped MERS-CoV infection, whereas the strongest T-cell responses were induced by this protein plus Freund’s and CpG adjuvants (Lan et al., 2014).
T298 1830-2006 Sentence denotes Vaccination pathways are important in inducing efficient immune responses, and different immunization routes may elicit different immune responses to the same protein antigens.
T299 2007-2323 Sentence denotes For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a).
T300 2324-2651 Sentence denotes In addition, while Freund’s and CpG-adjuvanted rRBD protein elicited higher-level systematic and local IFN-γ-producing T cells via the S.C. route, this protein adjuvanted with Alum and CpG induced higher-level tumor necrosis factor-alpha (TNF-α) and interleukin 4 (IL-4)-secreting T cells via the I.M. route (Lan et al., 2014).
T301 2652-2775 Sentence denotes Antigen dosage, immunization doses, and intervals may significantly affect the immunogenicity of MERS-CoV subunit vaccines.
T302 2776-3050 Sentence denotes Notably, a MERS-CoV RBD (S377-588-Fc) subunit vaccine immunized at 1 μg elicited strong humoral and cellular immune responses and neutralizing antibodies in mice although the one immunized at 5 and 20 μg elicited a higher level of S1-specific antibodies (Tang et al., 2015).
T303 3051-3298 Sentence denotes In addition, among the regimens at one dose and two doses at 1-, 2-, and 3-week intervals, 2 doses of this protein boosted at 4 weeks resulted in the highest antibodies and neutralizing antibodies against MERS-CoV infection (Wang Y. et al., 2017).

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T876 28-36 SP_9 denotes MERS-CoV
T877 65-73 SP_10 denotes SARS-CoV
T878 96-110 BV_15 denotes immunogenicity
T879 132-140 SP_9 denotes MERS-CoV
T880 211-218 CHEBI:59132;CHEBI:59132 denotes antigen
T881 248-257 CHEBI:60809;CHEBI:60809 denotes adjuvants
T882 281-288 CHEBI:59132;CHEBI:59132 denotes antigen
T883 355-363 SP_9 denotes MERS-CoV
T884 402-410 CHEBI:59132;CHEBI:59132 denotes antigens
T885 494-508 BV_15 denotes immunogenicity
T886 565-571 SO:0000417 denotes domain
T887 639-648 PG_1 denotes S protein
T888 682-692 GO:0042571 denotes antibodies
T889 764-773 CHEBI:60809;CHEBI:60809 denotes Adjuvants
T890 815-821 UBERON:0002405;GO:0006955 denotes immune
T891 822-831 GO:0006955 denotes responses
T892 835-843 SP_9 denotes MERS-CoV
T893 910-919 CHEBI:60809;CHEBI:60809 denotes adjuvants
T894 937-943 UBERON:0002405;GO:0006955 denotes immune
T895 944-953 GO:0006955 denotes responses
T896 1033-1041 SP_9 denotes MERS-CoV
T897 1133-1141 GO:0042571 denotes antibody
T898 1146-1152 CL:0000084 denotes T-cell
T899 1176-1180 NCBITaxon:10088 denotes mice
T900 1198-1206 CHEBI:60809;CHEBI:60809 denotes adjuvant
T901 1220-1234 CHEBI:60816;CHEBI:60816;BV_15 denotes immunogenicity
T902 1260-1269 CHEBI:60809;CHEBI:60809 denotes adjuvants
T903 1306-1313 CHEBI:47040;CHEBI:47040 denotes lipid A
T904 1341-1351 MOP:0000779 denotes conjugated
T905 1449-1459 GO:0042571 denotes antibodies
T906 1477-1487 GO:0042571 denotes antibodies
T907 1500-1504 NCBITaxon:10088 denotes mice
T908 1513-1521 SP_9 denotes MERS-CoV
T909 1615-1624 CHEBI:60809;CHEBI:60809 denotes adjuvants
T910 1659-1669 GO:0042571 denotes antibodies
T911 1690-1698 SP_9 denotes MERS-CoV
T912 1800-1809 CHEBI:60809;CHEBI:60809 denotes adjuvants
T913 1887-1893 UBERON:0002405;GO:0006955 denotes immune
T914 1894-1903 GO:0006955 denotes responses
T915 1960-1966 UBERON:0002405;GO:0006955 denotes immune
T916 1967-1976 GO:0006955 denotes responses
T917 1997-2005 CHEBI:59132;CHEBI:59132 denotes antigens
T918 2036-2040 NCBITaxon:10088 denotes mice
T919 2048-2056 SP_9 denotes MERS-CoV
T920 2132-2140 GO:0051716 denotes cellular
T921 2141-2147 UBERON:0002405;GO:0006955 denotes immune
T922 2148-2157 GO:0006955 denotes responses
T923 2177-2184 UBERON:0000912 denotes mucosal
T924 2198-2206 GO:0042571;GO:0016064 denotes antibody
T925 2207-2216 GO:0016064 denotes responses
T926 2225-2233 SP_9 denotes MERS-CoV
T927 2360-2370 CHEBI:60809;CHEBI:60809 denotes adjuvanted
T928 2427-2432 PR:000000017 denotes IFN-γ
T929 2443-2450 CL:0000084 denotes T cells
T930 2484-2494 CHEBI:60809;CHEBI:60809 denotes adjuvanted
T931 2534-2561 PR:000000134 denotes tumor necrosis factor-alpha
T932 2563-2568 PR:000000134 denotes TNF-α
T933 2574-2587 PR:000001391 denotes interleukin 4
T934 2589-2593 PR:000001391 denotes IL-4
T935 2595-2604 GO:0046903 denotes secreting
T936 2605-2612 CL:0000084 denotes T cells
T937 2652-2659 CHEBI:59132;CHEBI:59132 denotes Antigen
T938 2731-2745 BV_15 denotes immunogenicity
T939 2749-2757 SP_9 denotes MERS-CoV
T940 2787-2795 SP_9 denotes MERS-CoV
T941 2885-2891 UBERON:0002405 denotes immune
T942 2919-2929 GO:0042571 denotes antibodies
T943 2933-2937 NCBITaxon:10088 denotes mice
T944 3019-3029 GO:0042571 denotes antibodies
T945 3209-3219 GO:0042571 denotes antibodies
T946 3237-3247 GO:0042571 denotes antibodies
T947 3256-3264 SP_9 denotes MERS-CoV
T96788 28-36 SP_9 denotes MERS-CoV
T81363 65-73 SP_10 denotes SARS-CoV
T50826 96-110 BV_15 denotes immunogenicity
T27814 132-140 SP_9 denotes MERS-CoV
T74231 211-218 CHEBI:59132;CHEBI:59132 denotes antigen
T10867 248-257 CHEBI:60809;CHEBI:60809 denotes adjuvants
T27058 281-288 CHEBI:59132;CHEBI:59132 denotes antigen
T57743 355-363 SP_9 denotes MERS-CoV
T41190 402-410 CHEBI:59132;CHEBI:59132 denotes antigens
T74196 494-508 BV_15 denotes immunogenicity
T48211 565-571 SO:0000417 denotes domain
T31141 639-648 PG_1 denotes S protein
T37185 682-692 GO:0042571 denotes antibodies
T52744 764-773 CHEBI:60809;CHEBI:60809 denotes Adjuvants
T11857 815-821 UBERON:0002405;GO:0006955 denotes immune
T85159 822-831 GO:0006955 denotes responses
T26375 835-843 SP_9 denotes MERS-CoV
T98625 910-919 CHEBI:60809;CHEBI:60809 denotes adjuvants
T93717 937-943 UBERON:0002405;GO:0006955 denotes immune
T65360 944-953 GO:0006955 denotes responses
T96823 1033-1041 SP_9 denotes MERS-CoV
T38832 1133-1141 GO:0042571 denotes antibody
T55110 1146-1152 CL:0000084 denotes T-cell
T62891 1176-1180 NCBITaxon:10088 denotes mice
T6541 1198-1206 CHEBI:60809;CHEBI:60809 denotes adjuvant
T93532 1220-1234 CHEBI:60816;CHEBI:60816;BV_15 denotes immunogenicity
T57574 1260-1269 CHEBI:60809;CHEBI:60809 denotes adjuvants
T47385 1306-1313 CHEBI:47040;CHEBI:47040 denotes lipid A
T52510 1341-1351 MOP:0000779 denotes conjugated
T70169 1449-1459 GO:0042571 denotes antibodies
T65785 1477-1487 GO:0042571 denotes antibodies
T55866 1500-1504 NCBITaxon:10088 denotes mice
T88853 1513-1521 SP_9 denotes MERS-CoV
T95058 1615-1624 CHEBI:60809;CHEBI:60809 denotes adjuvants
T8567 1659-1669 GO:0042571 denotes antibodies
T62089 1690-1698 SP_9 denotes MERS-CoV
T52890 1800-1809 CHEBI:60809;CHEBI:60809 denotes adjuvants
T92188 1887-1893 UBERON:0002405;GO:0006955 denotes immune
T16517 1894-1903 GO:0006955 denotes responses
T23739 1960-1966 UBERON:0002405;GO:0006955 denotes immune
T55531 1967-1976 GO:0006955 denotes responses
T26614 1997-2005 CHEBI:59132;CHEBI:59132 denotes antigens
T39837 2036-2040 NCBITaxon:10088 denotes mice
T16700 2048-2056 SP_9 denotes MERS-CoV
T55053 2132-2140 GO:0051716 denotes cellular
T63741 2141-2147 UBERON:0002405;GO:0006955 denotes immune
T6035 2148-2157 GO:0006955 denotes responses
T53384 2177-2184 UBERON:0000912 denotes mucosal
T48624 2198-2206 GO:0042571;GO:0016064 denotes antibody
T90753 2207-2216 GO:0016064 denotes responses
T38294 2225-2233 SP_9 denotes MERS-CoV
T70153 2360-2370 CHEBI:60809;CHEBI:60809 denotes adjuvanted
T63512 2427-2432 PR:000000017 denotes IFN-γ
T80557 2443-2450 CL:0000084 denotes T cells
T8440 2484-2494 CHEBI:60809;CHEBI:60809 denotes adjuvanted
T7666 2534-2561 PR:000000134 denotes tumor necrosis factor-alpha
T21120 2563-2568 PR:000000134 denotes TNF-α
T60795 2574-2587 PR:000001391 denotes interleukin 4
T88872 2589-2593 PR:000001391 denotes IL-4
T34423 2595-2604 GO:0046903 denotes secreting
T31231 2605-2612 CL:0000084 denotes T cells
T12799 2652-2659 CHEBI:59132;CHEBI:59132 denotes Antigen
T1175 2731-2745 BV_15 denotes immunogenicity
T16192 2749-2757 SP_9 denotes MERS-CoV
T43587 2787-2795 SP_9 denotes MERS-CoV
T27719 2885-2891 UBERON:0002405 denotes immune
T84690 2919-2929 GO:0042571 denotes antibodies
T36027 2933-2937 NCBITaxon:10088 denotes mice
T11828 3019-3029 GO:0042571 denotes antibodies
T90238 3209-3219 GO:0042571 denotes antibodies
T72017 3237-3247 GO:0042571 denotes antibodies
T57398 3256-3264 SP_9 denotes MERS-CoV